Pseudomonal Infections

Slide 1 · Pseudomonal Infections

Opportunism • virulence • vascular injury • chronic airway disease

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

By the end of the lecture, explain:

Why P. Aeruginosa is dangerous in selected hosts and care settings.

How acute toxin-mediated injury differs from chronic biofilm infection.

The morphology of necrotizing pneumonia and vascular invasion.

How organ-specific syndromes follow from host and exposure context.

Slide 3 · A gram-negative opportunist

Pseudomonas aeruginosa

Aerobic, gram-negative bacillus.

Prominent opportunist rather than a uniform pathogen across hosts.

Potentially severe infection, often challenging to treat.

Opportunistic bacterium

Susceptible host or device

Local infection ± invasive disease

Slide 4 · Three high-risk host settings

The primary text emphasizes three clinically important contexts.

Cystic fibrosis

Persistent airway infection and progressive lung injury

Extensive burns

Deep tissue invasion with risk of bacteremia

Neutropenia

Serious invasive infection in an impaired host

Slide 5 · Environmental origin and transmission

Infection most often begins with an environmental source.

Environmental reservoir

Exposure or access to tissue

Infection in a permissive host

Person-to-person spread is described as less frequent.

Exposure alone does not determine severity; Host factors matter.

Slide 6 · The same organism, different syndromes

Context

Principal disease expression

Cystic fibrosis

Persistent respiratory infection

Intubation

Healthcare-associated respiratory infection

Urinary catheter

Healthcare-associated urinary infection

Skin burn

Deep invasion, possible sepsis

Contact lenses

Corneal keratitis

Slide 7 · Host condition shapes clinical expression

The route to infection depends on which host protection is compromised.

Disrupted barrier or device

Intubation • urinary catheter • burn wound

Impaired clearance or defense

Cystic fibrosis • neutropenia

Slide 8 · Cystic fibrosis as an airway niche

A defect in airway mucus clearance facilitates infection.

Thick secretions impair mucociliary removal of bacteria.

Small airways become obstructed by mucus.

Persistent organisms encounter a locally altered environment.

Viscous mucus

Poor clearance

P. Aeruginosa persistence

Slide 9 · Airway obstruction comes first

The sequence connects host disease to secondary bacterial infection.

Viscous mucus

Bronchial / bronchiolar plugging

Secondary airway infection

The source describes mucus plugging as a frequent antecedent of infection.

Infection amplifies the clinical effects of airway obstruction.

Slide 10 · Colonization can become chronic

The Robbins cystic fibrosis discussion describes a progression.

Initial

Intermittent lower-airway colonization

Persistent

Chronic colonization and biofilm formation

Established

Inflammatory damage and structural lung disease

Slide 11 · Mucus changes the local microenvironment

Static mucus helps create conditions favoring a mucoid phenotype.

Stagnant mucus

Hypoxic airway surface fluid

Alginate production

Hypoxia and alginate are explicitly linked in the Chapter 10 text.

This is a local airway mechanism, not generalized systemic hypoxia.

Slide 12 · Alginate supports biofilm formation

The bacterial extracellular matrix changes the infection.

Alginate is a mucoid polysaccharide made by the organism.

Biofilms contain alginate and other exopolysaccharides.

A matrix-associated bacterial community becomes persistent.

Alginate / exopolysaccharides

Biofilm organization

Protected bacterial community

Slide 13 · A biofilm is more than a bacterial mass

Biofilm organization has biological consequences.

Outside matrix

Bacteria exposed to antibodies, complement and phagocytes

Within matrix

Reduced access by host defenses and antibiotics

Slide 14 · Biofilms obstruct host clearance

Four host-defense or treatment obstacles.

Antibodies

Reduced effectiveness against embedded bacteria

Complement

Protection within the matrix

Phagocytes

Bacterial persistence despite cells

Antibiotics

Reduced treatment susceptibility

Slide 15 · Early infection and chronic infection differ

Early airway infection

Chronic biofilm-associated infection

Exotoxin A active

Exotoxin A output falls

Type III secretion expressed

Type III secretion expression declines

Strong direct toxin effects

Persistent inflammation and tissue enzymes

Acute cell injury

Progressive structural damage

Slide 16 · Exotoxin A has an intracellular target

Exotoxin A to diphtheria toxin.

Exotoxin A

ADP-ribosylation of EF-2

Protein synthesis inhibition

Host-cell death

EF-2 is the molecular target stated by the source.

The sequence illustrates the A–B toxin action at a conceptual level.

Slide 17 · Loss of protein synthesis is cytotoxic

Toxin-mediated interruption of translation injures the host cell.

EF-2 is required for normal protein synthesis.

Exotoxin A modification interrupts that process.

The end result is loss of host-cell viability.

Modified EF-2

Suppressed translation

Cell death

Slide 18 · The type III system delivers effectors

A specialized secretion apparatus transports bacterial effectors into host cells.

P. Aeruginosa

Type III secretion system

Host-cell effector proteins

Altered host defenses

Conceptual schematic; Not a microscopic image of the injectisome.

Slide 19 · Effector proteins weaken antibacterial ROS

An acute-phase virulence mechanism compromises host-cell defense.

Type III-delivered effectors diminish antibacterial reactive oxygen species.

This reduces one route by which host cells oppose the bacterium.

The effect favors persistence of the early infection.

Effector delivery

Less antibacterial ROS

Impaired local defense

Slide 20 · Effector proteins can induce apoptosis

The second effect noted in the source is host-cell apoptosis.

Injected effector proteins

Host-cell apoptotic response

Loss of host cells

The original paragraph is divided across columns in Markdown.

Apoptosis completion appears at robbins.md line 44059.

Slide 21 · Acute virulence has several components

Distinct mechanisms converge on local tissue injury.

Exotoxin A

Inhibition of host protein synthesis

Type III effectors

ROS suppression and apoptosis

Proteases

Extracellular tissue injury

Elastases

Additional enzymatic tissue damage

Slide 22 · Chronic infection alters virulence expression

Lower expression of several acute-phase features.

Chronic airway adaptation

Less exotoxin A and type III secretion

Less flagella and pili expression

Reduced expression should not be interpreted as eradication or harmlessness.

Slide 23 · Less acutely virulent does not mean benign

Persistent bacteria still injure lung tissue.

Biofilm protects the organism against clearance.

Ongoing inflammation damages the airway wall and surrounding tissue.

Proteases and elastases directly contribute to injury.

Persistent organisms

Inflammation + enzymes

Chronic tissue destruction

Slide 24 · Enzymes contribute to persistent damage

Chronic disease includes toxin-independent injury mechanisms.

Proteases + elastases

Local tissue degradation

Progressive lung injury

Schematic causal relationship described in the source.

Slide 25 · Inflammation can be ineffective and harmful

An important host–pathogen paradox in cystic fibrosis.

Immune response continues

Antibody- and cell-mediated responses against the organism

Bacterial persistence continues

Inflammatory injury despite inadequate elimination

Slide 26 · Two routes to antibiotic resistance

Two interacting explanations for difficult treatment.

Biofilm-related effect

Matrix-associated protection against antibiotics

Genetic effect

Antibiotic resistance caused by bacterial genetic change

Slide 27 · Biofilm protection differs from genetic change

Biofilm-related protection

Genetic resistance

Community-level protection by extracellular matrix

Heritable changes in the bacterial population

Limits effectiveness of antibiotics in situ

Adds resistance beyond the matrix effect

Contributes to chronic persistence

Further complicates treatment

Slide 28 · Resistance changes clinical difficulty

Why infections may persist despite an active host response and therapy.

A protected bacterial population is harder to eradicate.

Genetic adaptation can compound antibiotic resistance.

Ongoing infection perpetuates inflammation and lung damage.

Biofilm + genetic changes

Treatment difficulty

Chronic pulmonary injury

Slide 29 · Chronic cystic fibrosis lung disease

A coherent clinicopathologic chain.

Mucus retention

Pseudomonal persistence

Chronic inflammation

Bronchiectasis + fibrosis

The terminal lesions are explicitly named in the main topic.

Slide 30 · Bronchiectasis is a structural endpoint

Chronic infection is linked to abnormal bronchial architecture.

Bronchiectasis as a consequence of persistent infection.

Obstructed airways and repeated inflammation precede structural damage.

The abnormal airway then remains vulnerable to retained secretions.

Chronic infection

Airway wall damage

Bronchiectasis

Slide 31 · Pulmonary fibrosis reflects lasting injury

The infection may leave permanent parenchymal damage.

Repeated inflammation and tissue damage accumulate.

The main source identifies pulmonary fibrosis as a chronic consequence.

Fibrosis adds to the persistent functional burden of airway disease.

Chronic damage

Fibrotic remodeling

Long-term lung disease

Slide 32 · Hospital-acquired infection depends on context

The primary text gives two characteristic device-linked syndromes.

Intubated airway

Healthcare-associated respiratory infection

Urinary catheter

Healthcare-associated urinary infection

Burn unit

Infected wounds with possible sepsis

Slide 33 · Intubation-associated respiratory infection

An invasive airway device identifies a susceptible clinical setting.

Airway instrumentation

Hospital-acquired infection

Potential severe pneumonia

This is a context diagram; Specific device-associated causal microbiology is not detailed by the source.

Slide 34 · Catheter-associated urinary infection

The same pathogen can infect a different organ system.

P. Aeruginosa causes urinary tract infections associated with urinary catheters.

This is a healthcare-associated clinical manifestation.

Host/device history is important when interpreting cultures.

Urinary catheter context

Pseudomonal UTI

Clinical assessment

Slide 35 · Severe burns permit invasive infection

Infected burn surfaces can become a source of systemic disease.

Extensive skin burn

P. Aeruginosa proliferation

Deep tissue / venous penetration

Hematogenous spread

Textbook explicitly describes extension deep into veins.

Slide 36 · Vascular invasion is a central theme

Pseudomonal disease repeatedly targets vessels.

In burns, organisms penetrate deeply into veins.

In pneumonia, organisms may concentrate in vessel walls.

Vascular injury is linked to necrosis, thrombosis and hemorrhage.

Bacterial vessel involvement

Vascular wall damage

Thrombotic + hemorrhagic injury

Slide 37 · Why hematogenous spread matters

Local infection may escalate to systemic complications.

Deep vascular access

Bacteremia / systemic spread

Potential fulminant disease

Complemented by Chapter 15 description of fulminant Pseudomonas septicemia.

Slide 38 · Ecthyma gangrenosum is a vascular clue

Characteristic skin lesion described in disseminated infection.

Well-demarcated, oval lesions are emphasized.

They are necrotic and hemorrhagic.

The lesion is associated with burn infection and hematogenous spread in the source.

Invasive infection

Skin necrosis + hemorrhage

Ecthyma gangrenosum

Slide 39 · Bacteremia can provoke DIC

The main text calls disseminated intravascular coagulation a frequent complication.

P. Aeruginosa bacteremia

Systemic coagulation derangement

DIC

No numerical incidence is inferred.

Slide 40 · Risk and lesion pattern together

Predisposing context

Associated important pathology

Neutropenia

Severe invasive Pseudomonas infection

Burn wound

Venous penetration, dissemination, ecthyma gangrenosum

Cystic fibrosis

Persistent infection, bronchiectasis, pulmonary fibrosis

Hospital intubation

Respiratory infection / pneumonia

Slide 41 · Necrotizing pneumonia: Gross pattern

The defining morphology combines necrosis and hemorrhage.

Distribution follows terminal airways.

Pale zones represent necrotic centers.

Red peripheral zones represent hemorrhage.

Terminal airway distribution

Pale necrotic center

Red hemorrhagic edge

Slide 42 · Fleur-de-lis describes lesion distribution

The source uses a branching, terminal-airway pattern.

Terminal airway branching

Branch-centered pulmonary injury

Fleur-de-lis distribution

A relational schematic, not a literal gross image.

Slide 43 · Necrosis and hemorrhage coexist

Two distinct injury components appear in the same lesion.

Pale center

Tissue necrosis

Red peripheral zone

Hemorrhagic tissue

Slide 44 · Microscopic bacillary aggregates

The source highlights organism-rich microscopic fields.

Organisms may be present in large masses.

They are often concentrated in blood-vessel walls.

The finding should be interpreted with the associated vascular injury.

Numerous bacteria

Vessel-wall localization

Damaged host tissue

Slide 45 · Coagulative necrosis of host tissue

Bacteria in vascular walls are associated with necrosis.

Vascular wall bacteria

Host-cell coagulative necrosis

Necrotizing bacterial vasculitis

This diagram depicts causal text; Not a histologic specimen.

Slide 46 · Thrombosis amplifies vascular pathology

The microscopic description links inflammation with thrombi and hemorrhage.

Vascular infection / injury

Thrombosis

Local ischemic and hemorrhagic injury

The distal phrase is a clinicopathologic inference from vascular occlusion; The main text states thrombosis and hemorrhage.

Slide 47 · The vascular morphology triad

A suggestive constellation in the appropriate host.

Gram-negative bacilli

Organism-rich vessels

Necrotizing vasculitis

Host-cell coagulative necrosis

Thrombosis

Occluded injured vessels

Hemorrhage

Extravascular bleeding

Slide 48 · Schematic: Infected vessel wall

Vessel-wall localization is the central morphologic relationship.

Bacterial aggregates

Vessel-wall injury

Luminal thrombus

Hemorrhage

Schematic — not a histologic specimen

Slide 49 · Vascular pattern is suggestive, not specific

Avoid equating a characteristic pattern with a definitive organism identification.

Supported interpretation

Strongly suggests P. Aeruginosa when context fits

Overstatement

Histology alone proves the bacterial species

Slide 50 · Pathology links lung and skin disease

Lung

Skin / burns

Terminal airway-centered necrosis

Deep infection of burned tissue

Organism-rich vessel walls

Venous penetration

Thrombosis and hemorrhage

Necrotic hemorrhagic skin lesions

Risk of invasive spread

Risk of bacteremia and DIC

Slide 51 · The eye: Contact lens–associated keratitis

A local infection in a host without classic systemic immunodeficiency.

Contact lens wear is the characteristic exposure in the source.

P. Aeruginosa can infect the cornea.

Anatomic site and exposure narrow the clinical suspicion.

Contact lens exposure

Corneal infection

Keratitis

Slide 52 · Otitis externa spans host groups

Clinical group

Syndrome emphasized

Otherwise healthy person

External otitis (“swimmer’s ear”)

Person with diabetes

Severe external otitis

Slide 53 · Injection drug use: Invasive foci

Two focal infections are named in the main source.

P. Aeruginosa may cause endocarditis.

Osteomyelitis is another recognized manifestation.

Exposure context raises suspicion for deep-seated infection.

Injection drug exposure

Endocarditis or osteomyelitis

Deep focal infection

Slide 54 · Clinical phenotype is host-specific

Host / exposure

Characteristic presentation

Cystic fibrosis

Chronic airway colonization and damage

Severe burns

Invasive wound infection ± bacteremia

Contact lens use

Keratitis

Diabetes

Severe external otitis

Injection drug use

Endocarditis; osteomyelitis

Slide 55 · Reasoning from host to suspected pathogen

Clinical suspicion uses context before microscopic confirmation.

Identify high-risk host

Identify affected organ

Evaluate morphology and infection evidence

This is an educational reasoning framework, not a validated diagnostic algorithm.

Slide 56 · Avoid mistaking morphology for identification

Interpret tissue findings in a clinically coherent way.

Vasculitis with abundant gram-negative organisms, thrombosis and hemorrhage is strongly suggestive.

This pattern is not pathognomonic.

Species identification therefore requires organism-directed microbiologic evidence.

Slide 57 · Histologic evidence and clinical context

Neither category should be interpreted in isolation.

Tissue pattern

Vascular organism masses • coagulative necrosis • hemorrhage

Clinical setting

Neutropenia • burns • CF • intensive-care exposure

Slide 58 · A practical syndrome–mechanism matrix

Syndrome

Mechanistic emphasis

Early lung infection

Exotoxin A / type III effectors

Chronic CF lung infection

Alginate biofilm / inflammation / enzymes

Necrotizing pneumonia

Angioinvasion with hemorrhagic necrosis

Sepsis after burns

Vascular invasion and dissemination

Slide 59 · Case: Progressive lung disease in cystic fibrosis

A person with cystic fibrosis has persistent P. Aeruginosa infection despite treatment, with progressive airway damage.

Which transition best explains persistence?

A. Formation of alginate-associated biofilm

B. Complete loss of bacterial tissue-damaging capacity

Slide 60 · Case: Necrotic lesions after severe burns

After extensive burns, a patient develops well-circumscribed oval lesions containing necrosis and hemorrhage.

What systemic complication is especially important to consider?

A. Pseudomonal bacteremia with possible DIC

B. An isolated noninvasive superficial eruption

Slide 61 · Case: Hemorrhagic necrotizing pneumonia

A neutropenic patient develops rapidly progressive pneumonia. Tissue shows abundant gram-negative bacilli concentrated around vessel walls, with thrombosis and hemorrhage.

How specific is the morphologic pattern?

A. Highly suggestive, not pathognomonic

B. Definitive organism identification from morphology alone

Slide 62 · Two modes of pseudomonal injury

A concise unifying model.

Acute / invasive

Exotoxin A • type III effectors • vascular necrosis

Persistent / chronic

Alginate biofilm • inflammatory injury • enzymes

Slide 63 · Integrated clinicopathologic summary

Four associations capture the teaching unit.

Host

CF, burns and neutropenia drive major susceptibility

Pathogenesis

Early toxins → chronic biofilm adaptation

Morphology

Necrotizing hemorrhagic pneumonia and vasculitis

Consequences

Bronchiectasis, fibrosis, sepsis and DIC

Slide 64 · Source basis

Primary textbook

Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th edition (2026).

Pseudomonal Infections, in Infectious Diseases.

Related reading within Robbins: cystic fibrosis and bacterial pneumonia.